| Future Health Pharma GmbH - Matrifen 50 ug/h, Transdermales Pflaster | | 57460 | | 02 | | Matrifen 50 ug/h | | Transdermales Pflaster | | N02AB03 | | Fentanyl | | 22.11.2007 | | |
| | Composition | | fentanylum 5.5 mg, dipropylenglycolum, hydroxypropylcellulosum, silicone adhesive, dimeticonum 350, ethyleni et vinylis acetatis polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte: Türkis, ad praeparationem pro 16.8 cm² cum liberatione 50 µg/h. | | Packungsbestandteile | | Transdermal System | | | | | | Active Agent | Dose |
|---|
| Fentanyl | 5.5 mg |
| | | | Inactive agents |
|---|
| Dipropylenglycol |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 007 | 5 plaster(s) | PR | PR | A+ | | Yes | | 019 | 10 plaster(s) | PR | PR | A+ | | Yes |
|
|
